CYCLERION THERAPEUTICS CYCN 深 沪
已收盘 12-12 16:00:00 美东时间
1.51
-0.170
-10.12%
华盛通- 最 高1.64
- 今 开1.64
- 成交量 6.43万股
- 最 低 1.43
- 昨 收 1.68
- 总市值 592.72万
- 52周最高 6.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.28
- 委 比 -67.02%
- 总股本 392.53万
- 历史最高 296.60
- 量 比 1.33
- 振 幅 12.50%
- 历史最低 1.27
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cyclerion Receives Milestone Payment from Akebia
Cyclerion Therapeutics ( ($CYCN) ) has issued an update. On December 1, 2025, A...
12-02 06:28
Akebia Announces Establishment of Rare Kidney Disease Pipeline
Akebia Therapeutics announced the establishment of its rare kidney disease pipeline, acquiring AKB-097, a tissue-targeted complement inhibitor, from Q32 Bio, and initiating a Phase 2 trial for praliciguat in FSGS. AKB-097, designed to address complement-mediated kidney diseases without systemic inhibition, is set to begin Phase 2 basket trials in 2026, with data expected in 2027. Praliland其它早期披露要求请联系trial in FSGS is also planned to start in 2026....
12-01 12:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
11-11 20:07
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network
Cycurion, Inc (NASDAQ: CYCU) secures contract for $1 million to modernize federal government's critical communication network over 24-36 months.
11-10 22:16
Cycurion, Inc. Announces Reverse Stock Split Effective October 27, 2025, for Purpose of Remaining Nasdaq Compliant
Cycurion Inc. (NASDAQ: CYCU), a cybersecurity solutions provider, announced that its previously announced 1-for-30 reverse stock split will take effect on October 27, 2025, reducing the number of outstanding shares from approximately 86.5 million to 2.88 million. Stockholders will not receive fractional shares; instead, they will be paid in cash for any fractional shares based on the closing price prior to the effective date. Proportionate adjust...
10-23 15:00
Cycurion, Inc. Announces Nasdaq Delisting Determination Letter
Cycurion, Inc. (NASDAQ: CYCU) received a delisting determination letter from Nasdaq on October 14, 2025, after its common stock closed below $1.00 for 30 consecutive days. The company failed to regain compliance with Nasdaq's Bid Price Rule by the October 6, 2025 deadline. Cycurion submitted an appeal request to a Hearings Panel on October 20, 2025, which could delay the delisting process. The company also implemented a 30:1 reverse stock split e...
10-20 20:30
Stocks to Watch: Aytu BioPharma, Cohu, Cyclerion
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-24 07:17
Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus
Cyclerion Therapeutics ( ($CYCN) ) has issued an update. On September 19, 2025,...
09-24 05:13
快讯 | Cyclerion Therapeutics - 根据许可协议，Mit有资格获得高达440万美元的里程碑付款 - SEC文件
Cyclerion Therapeutics - Under License Agreement, Mit Eligible for up to $4.4 M...
09-24 04:19
Cyclerion Announces License Agreement With MIT To Relaunch Advancing Phase 2–Ready Treatment For Resistant Depression
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement –– Webcast to be held September 24, 2025 at 10:30 a.m.
09-24 04:04
